Evolution of hemangioma endothelium

Experimental and Molecular Pathology

Volumn 93, Issue 2, 2012, Pages 264-272

  Kleiman, Alexandra ^a   Keats, Emily C ^a   Chan, Nancy G ^a,b   Khan, Zia A ^a,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LONDON HEALTH SCIENCES CENTRE   (Canada)

^c LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Angiogenesis; Cell differentiation; Endothelial cells; Endothelial progenitor cells; Hemangioma; Matrix proteins; Vasculogenesis

Indexed keywords

ALPHA2A INTERFERON; CORTICOSTEROID; PROPRANOLOL;

ADIPOCYTE; CAPILLARY HEMANGIOMA; CELL DIFFERENTIATION; CELL FATE; CELL POPULATION; CEREBRAL PALSY; CLINICAL FEATURE; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; EDEMA; ENDOTHELIUM; ENDOTHELIUM CELL; EXCISION; GROWTH RETARDATION; HUMAN; IMMUNE DEFICIENCY; IRRITABILITY; MALAISE; MOLECULAR MECHANICS; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; STEM CELL; TUMOR CLASSIFICATION; TUMOR GROWTH; TUMOR REGRESSION;

ENDOTHELIUM, VASCULAR; HEMANGIOMA, CAPILLARY; HUMANS; MULTIPOTENT STEM CELLS; NEOPLASTIC SYNDROMES, HEREDITARY; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84862737840     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2012.04.020     Document Type: Review

References (80)

1. Amir J., Metzker A., Krikler R., Reisner S.H. Strawberry hemangioma in preterm infants. Pediatric Dermatology 1986, 3:331-332.
2. Barlow C.F., Priebe C.J., Mulliken J.B., Barnes P.D., Mac Donald D., Folkman J., Ezekowitz R.A. Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancy. The Journal of Pediatrics 1998, 132:527-530.
3. Beck D.O., Gosain A.K. The presentation and management of hemangiomas. Plastic and Reconstructive Surgery 2009, 123:181e-191e.
4. Berse B., Brown L.F., Van de Water L., Dvorak H.F., Senger D.R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Molecular Biology of the Cell 1992, 3:211-220.
5. Bielenberg D.R., Bucana C.D., Sanchez R., Mulliken J.B., Folkman J., Fidler I.J. Progressive growth of infantile cutaneous hemangiomas is directly correlated with hyperplasia and angiogenesis of adjacent epidermis and inversely correlated with expression of the endogenous angiogenesis inhibitor, IFN-beta. International Journal of Oncology 1999, 14:401-408.
6. Boscolo E., Mulliken J.B., Bischoff J. VEGFR-1 mediates endothelial differentiation and formation of blood vessels in a murine model of infantile hemangioma. The American Journal of Pathology 2011, 179:2266-2277.
7. Boscolo E., Stewart C.L., Greenberger S., Wu J.K., Durham J.T., Herman I.M., Mulliken J.B., Kitajewski J., Bischoff J. JAGGED1 signaling regulates hemangioma stem cell-to-pericyte/vascular smooth muscle cell differentiation. Arteriosclerosis, Thrombosis, and Vascular Biology 2011, 31:2181-2192.
8. Boye E., Yu Y., Paranya G., Mulliken J.B., Olsen B.R., Bischoff J. Clonality and altered behavior of endothelial cells from hemangiomas. The Journal of Clinical Investigation 2001, 107:745-752.
9. Bree A.F., Siegfried E., Sotelo-Avila C., Nahass G. Infantile hemangiomas: speculation on placental trophoblastic origin. Archives of Dermatology 2001, 137:573-577.
10. Bruckner A.L., Frieden I.J. Hemangiomas of infancy. Journal of the American Academy of Dermatology 2003, 48:477-493.
11. Bruckner A.L., Frieden I.J. Infantile hemangiomas. Journal of the American Academy of Dermatology 2006, 55:671-682.
12. Burton B.K., Schulz C.J., Angle B., Burd L.I. An increased incidence of haemangiomas in infants born following chorionic villus sampling (CVS). Prenatal Diagnosis 1995, 15:209-214.
13. Chiller K.G., Passaro D., Frieden I.J. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Archives of Dermatology 2002, 138:1567-1576.
14. Cohen M.M. Hemangiomas: their uses and abuses. American Journal of Medical Genetics. Part A 2007, 143:235-240.
15. Cooper A.G., Bolande R.P. Multiple hemangiomas in an infant with cardiac hypertrophy. Postmortem angiographic demonstration of the arteriovenous fistulae. Pediatrics 1965, 35:27-35.
16. Dore-Duffy P., Cleary K. Morphology and properties of pericytes. Methods in Molecular Biology 2011, 686:49-68.
17. Dosanjh A., Chang J., Bresnick S., Zhou L., Reinisch J., Longaker M., Karasek M. In vitro characteristics of neonatal hemangioma endothelial cells: similarities and differences between normal neonatal and fetal endothelial cells. Journal of Cutaneous Pathology 2000, 27:441-450.
18. Enjolras O., Mulliken J.B. The current management of vascular birthmarks. Pediatric Dermatology 1993, 10:311-313.
19. Enjolras O., Riche M.C., Merland J.J., Escande J.P. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 1990, 85:491-498.
20. Ferrara N. The role of VEGF in the regulation of physiological and pathological angiogenesis. EXS 2005, 209-231.
21. Fost N.C., Esterly N.B. Successful treatment of juvenile hemangiomas with prednisone. The Journal of Pediatrics 1968, 72:351-357.
22. Frieden I.J., Eichenfield L.F., Esterly N.B., Geronemus R., Mallory S.B. Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee. Journal of the American Academy of Dermatology 1997, 37:631-637.
23. Froehner S.C., Davies A., Baldwin S.A., Lienhard G.E. The blood-nerve barrier is rich in glucose transporter. Journal of Neurocytology 1988, 17:173-178.
24. Gonzalez-Crussi F., Reyes-Mugica M. Cellular hemangiomas ("hemangioendotheliomas") in infants. Light microscopic, immunohistochemical, and ultrastructural observations. The American Journal of Surgical Pathology 1991, 15:769-778.
25. Gould G.W., Holman G.D. The glucose transporter family: structure, function and tissue-specific expression. The Biochemical Journal 1993, 295(Pt. 2):329-341.
26. Greenberger S., Yuan S., Walsh L.A., Boscolo E., Kang K.T., Matthews B., Mulliken J.B., Bischoff J. Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangioma. The Journal of Investigative Dermatology 2011, 131:2467-2476.
27. Greinwald J.H., Burke D.K., Bonthius D.J., Bauman N.M., Smith R.J. An update on the treatment of hemangiomas in children with interferon alfa-2a. Archives of Otolaryngology - Head & Neck Surgery 1999, 125:21-27.
28. Haggstrom A.N., Drolet B.A., Baselga E., Chamlin S.L., Garzon M.C., Horii K.A., Lucky A.W., Mancini A.J., Metry D.W., Newell B., Nopper A.J., Frieden I.J. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006, 118:882-887.
29. Haggstrom A.N., Lammer E.J., Schneider R.A., Marcucio R., Frieden I.J. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 2006, 117:698-703.
30. Holmdahl K. Cutaneous hemangiomas in premature and mature infants. Acta Paediatrica 1955, 44:370-379.
31. Holmes L.B. Chorionic villus sampling and hemangiomas. The Journal of Craniofacial Surgery 2009, 20(Suppl. 1):675-677.
32. Hopfel-Kreiner I. Histogenesis of hemangiomas-an ultrastructural study on capillary and cavernous hemangiomas of the skin. Pathology, Research and Practice 1980, 170:70-90.
33. Huber P.A. Caldesmon. The International Journal of Biochemistry & Cell Biology 1997, 29:1047-1051.
34. Jansson T., Wennergren M., Illsley N.P. Glucose transporter protein expression in human placenta throughout gestation and in intrauterine growth retardation. The Journal of Clinical Endocrinology and Metabolism 1993, 77:1554-1562.
35. Jinnin M., Medici D., Park L., Limaye N., Liu Y., Boscolo E., Bischoff J., Vikkula M., Boye E., Olsen B.R. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nature Medicine 2008, 14:1236-1246.
36. Jones N., Dumont D.J. Tek/Tie2 signaling: new and old partners. Cancer Metastasis Reviews 2000, 19:13-17.
37. Kaplan P., Normandin J., Wilson G.N., Plauchu H., Lippman A., Vekemans M. Malformations and minor anomalies in children whose mothers had prenatal diagnosis: comparison between CVS and amniocentesis. American Journal of Medical Genetics 1990, 37:366-370.
38. Kearney J.B., Ambler C.A., Monaco K.A., Johnson N., Rapoport R.G., Bautch V.L. Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division. Blood 2002, 99:2397-2407.
39. Khan Z.A., Melero-Martin J.M., Wu X., Paruchuri S., Boscolo E., Mulliken J.B., Bischoff J. Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to endostatin. Blood 2006, 108:915-921.
40. Khan Z.A., Boscolo E., Picard A., Psutka S., Melero-Martin J.M., Bartch T.C., Mulliken J.B., Bischoff J. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. The Journal of Clinical Investigation 2008, 118:2592-2599.
41. Krol A., MacArthur C.J. Congenital hemangiomas: rapidly involuting and noninvoluting congenital hemangiomas. Archives of Facial Plastic Surgery 2005, 7:307-311.
42. Leaute-Labreze C., Dumas de la Roque E., Hubiche T., Boralevi F., Thambo J.B., Taieb A. Propranolol for severe hemangiomas of infancy. The New England Journal of Medicine 2008, 358:2649-2651.
43. Li Q., Yu Y., Bischoff J., Mulliken J.B., Olsen B.R. Differential expression of CD146 in tissues and endothelial cells derived from infantile haemangioma and normal human skin. The Journal of Pathology 2003, 201:296-302.
44. Lo K., Mihm M., Fay A. Current theories on the pathogenesis of infantile hemangioma. Seminars in Ophthalmology 2009, 24:172-177.
45. MacArthur C.J., Senders C.W., Katz J. The use of interferon alfa-2a for life-threatening hemangiomas. Archives of Otolaryngology - Head & Neck Surgery 1995, 121:690-693.
46. Maisonpierre P.C., Suri C., Jones P.F., Bartunkova S., Wiegand S.J., Radziejewski C., Compton D., McClain J., Aldrich T.H., Papadopoulos N., Daly T.J., Davis S., Sato T.N., Yancopoulos G.D. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997, 277:55-60.
47. Malan E. Vascular Anomalies (Angiodysplasias) 1974, 17. Carlo Erba Foundation, Milan.
48. Millauer B., Wizigmann-Voos S., Schnurch H., Martinez R., Moller N.P., Risau W., Ullrich A. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993, 72:835-846.
49. Mulliken J.B. A biologic approach to cutaneous vascular anomalies. Pediatric Dermatology 1992, 9:356-357.
50. Mulliken J.B. Cutaneous vascular anomalies. Seminars in Vascular Surgery 1993, 6:204-218.
51. Mulliken J.B., Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plastic and Reconstructive Surgery 1982, 69:412-422.
52. Mulliken J.B., Young A.E. Classifications of Vascular Birthmarks. Vascular Birthmarks: Hemangiomas and Malformations 1988, 24-37. W.B. Saunders, Philadelphia.
53. Nguyen J., Fay A. Pharmacologic therapy for periocular infantile hemangiomas: a review of the literature. Seminars in Ophthalmology 2009, 24:178-184.
54. North P.E., Waner M., Mizeracki A., Mihm M.C. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Human Pathology 2000, 31:11-22.
55. North P.E., Waner M., Mizeracki A., Mrak R.E., Nicholas R., Kincannon J., Suen J.Y., Mihm M.C. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Archives of Dermatology 2001, 137:559-570.
56. North P.E., Waner M., Brodsky M.C. Are infantile hemangiomas of placental origin?. Ophthalmology 2002, 109:633-634.
57. Pack G.T., Miller T.R. Hemangiomas; classification, diagnosis and treatment. Angiology 1950, 1:405-426.
58. Pasyk K.A., Cherry G.W., Grabb W.C., Sasaki G.H. Quantitative evaluation of mast cells in cellularly dynamic and adynamic vascular malformations. Plastic and Reconstructive Surgery 1984, 73:69-77.
59. Rhoads G.G., Jackson L.G., Schlesselman S.E., de la Cruz F.F., Desnick R.J., Golbus M.S., Ledbetter D.H., Lubs H.A., Mahoney M.J., Pergament E., et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. The New England Journal of Medicine 1989, 320:609-617.
60. Ritter M.R., Reinisch J., Friedlander S.F., Friedlander M. Myeloid cells in infantile hemangioma. The American Journal of Pathology 2006, 168:621-628.
61. Ritter M.R., Butschek R.A., Friedlander M., Friedlander S.F. Pathogenesis of infantile haemangioma: new molecular and cellular insights. Expert Reviews in Molecular Medicine 2007, 9:1-19.
62. Roberts D.M., Kearney J.B., Johnson J.H., Rosenberg M.P., Kumar R., Bautch V.L. The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation. The American Journal of Pathology 2004, 164:1531-1535.
63. Sato T.N., Tozawa Y., Deutsch U., Wolburg-Buchholz K., Fujiwara Y., Gendron-Maguire M., Gridley T., Wolburg H., Risau W., Qin Y. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995, 376:70-74.
64. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845.
65. Smolinski K.N., Yan A.C. Hemangiomas of infancy: clinical and biological characteristics. Clinical Pediatrics 2005, 44:747-766.
66. Smoller B.R., Apfelberg D.B. Infantile (juvenile) capillary hemangioma: a tumor of heterogeneous cellular elements. Journal of Cutaneous Pathology 1993, 20:330-336.
67. Sun Z.J., Zhao Y.F., Zhao J.H. Mast cells in hemangioma: a double-edged sword. Medical Hypotheses 2007, 68:805-807.
68. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 1996, 87:1171-1180.
69. Tan S.T., Wallis R.A., He Y., Davis P.F. Mast cells and hemangioma. Plastic and Reconstructive Surgery 2004, 113:999-1011.
70. Virchow R.A. Die krankhaften geschweulste 1863, August Hirschwald, Berlin, 306pp.
71. Walter J.W., North P.E., Waner M., Mizeracki A., Blei F., Walker J.W., Reinisch J.F., Marchuk D.A. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes, Chromosomes & Cancer 2002, 33:295-303.
72. Waner M., North P.E., Scherer K.A., Frieden I.J., Waner A., Mihm M.C. The nonrandom distribution of facial hemangiomas. Archives of Dermatology 2003, 139:869-875.
73. Weber T.R., Connors R.H., Tracy T.F., Bailey P.V. Complex hemangiomas of infants and children. Individualized management in 22 cases. Archives of Surgery 1990, 125:1017-1020.
74. Worle H., Maass E., Kohler B., Treuner J. Interferon alpha-2a therapy in haemangiomas of infancy: spastic diplegia as a severe complication. European Journal of Pediatrics 1999, 158:344.
75. Yamagishi S., Imaizumi T. Pericyte biology and diseases. International Journal of Tissue Reactions 2005, 27:125-135.
76. Yamagishi S., Hsu C.C., Kobayashi K., Yamamoto H. Endothelin 1 mediates endothelial cell-dependent proliferation of vascular pericytes. Biochemical and Biophysical Research Communications 1993, 191:840-846.
77. Yamagishi S., Kobayashi K., Yamamoto H. Vascular pericytes not only regulate growth, but also preserve prostacyclin-producing ability and protect against lipid peroxide-induced injury of co-cultured endothelial cells. Biochemical and Biophysical Research Communications 1993, 190:418-425.
78. Yu Y., Varughese J., Brown L.F., Mulliken J.B., Bischoff J. Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. The American Journal of Pathology 2001, 159:2271-2280.
79. Yu Y., Flint A.F., Mulliken J.B., Wu J.K., Bischoff J. Endothelial progenitor cells in infantile hemangioma. Blood 2004, 103:1373-1375.
80. Yuan S.M., Chen R.L., Shen W.M., Chen H.N., Zhou X.J. Mesenchymal stem cells in infantile hemangioma reside in the perivascular region. Pediatric and Developmental Pathology 2012, 15:5-12.